NASHVILLE, Tenn.& TAIPEI, Taiwan---- Harrow, a leading North American eyecare pharmaceutical company, and Taiwan- based Formosa Pharmaceuticals, today announced a licensing agreement, whereby ...

BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05%, for topical ophthalmic use INDICATIONS AND USAGE BYQLOVI is a corticosteroid indicated for the treatment of post-operative inflammation ...

Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals. Business Wire; Jun 9, 2025 Jun 9, 2025; ...

The main investment objective of a liquid fund is the preservation of capital… not generating high returns. The 1-year returns of liquid funds is 7%, while the 2-year compounded annualised ...

A simple and sensitive liquid chromatographic method was developed and validated for clobetasol determination in different skin layers. NLCs presented uniform size distribution, high zeta potentialand ...

Clobetasol propionate ophthalmic suspension, 0.05% (APP13007) was approved by the Food and Drug Administration in 2024. APP13007's active ingredient is the superpotent corticosteroid, ...

TAIPEI, May 7, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ('Formosa', 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc.

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc ...

NastLaw LLC Announces a Class Action Lawsuit For Those Who May Have Purchased Clobetasol at Anytime From June 3, 2014 to December 31, 2018 OR Purchased Clomipramine at Anytime From May 1, 2013 to ...

Excluded from the Clobetasol Class are (a) he Defendants and former defendants [] and their officers, directors, management, employees, subsidiaries, or affiliates, (b) judicial officers and their ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Researchers have discovered a "shape-recovering liquid" that appears to defy the laws of ...

Comparação da eficácia do clobetasol em esmalte 0,05%, 1% e 8% no tratamento da psoríase ungueal: estudo piloto, ... The nail lacquer is a solution to avoid the adverse effects caused by the use of ...